EMEA-003236-PIP01-22
Key facts
| Active substance |
Gallium 68-labelled Prostate-Specific Membrane Antigen-11 (68Ga-PSMA-11)
|
| Therapeutic area |
Oncology
|
| Decision number |
P/0361/2022
|
| PIP number |
EMEA-003236-PIP01-22
|
| Pharmaceutical form(s) |
All pharmaceutical forms
|
| Condition(s) / indication(s) |
Visualisation of prostate specific membrane antigen in prostate cancer
|
| Route(s) of administration |
All routes of administration
|
| Contact for public enquiries |
ROTOP Pharmaka GmbH
Tel. +49 35126310251 |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|